- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, July 28, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An opinion piece in The Hill referenced a study published in the June 2023 issue of The American Journal of Managed Care® (AJMC®). The study, “Income Differences Between Locations of 340B Entities and Contract Pharmacies,” found that 340B-covered hospitals and grantees were contracting with pharmacies in more affluent neighborhoods.
An article from Medical Xpress referenced a study to be published in the October 2023 issue of AJMC. The study, “Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net,” evaluated the effect of Choosing Wisely on antibiotic prescribing in viral respiratory tract infections in a real-world safety-net setting.
An article from Becker’s Payer Issues referenced a study published in the July 2023 issue of AJMC. The study, “Social Determinants of Health and High-Cost Utilization Among Commercially Insured Population,” found that living in a disadvantaged neighborhood was associated with a higher likelihood of being a high-cost utilizer in older adults and lower likelihood in younger adults.
An article by HealthcareITNews referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Contributor: Telehealth Utilization Grew 7% Nationally in January 2023,” featured statistics on how the utilization of telehealth had increased nationally in the first month of 2023.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Clarifying the Role of EEN Diet as Ulcerative Colitis Therapy
March 12th 2025There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, despite its good tolerability and low discontinuation rates, according to a systematic review.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
